Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development

PURPOSE: Glioblastoma (GBM) is the most common primary brain tumor in adults and is notorious for its lethality. Given its limited therapeutic measures and high heterogeneity, the development of new individualized therapies is important. mRNA vaccines have exhibited promising performance in a variet...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Changwu, Qin, Chaoying, Long, Wenyong, Wang, Xiangyu, Xiao, Kai, Liu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281265/
https://www.ncbi.nlm.nih.gov/pubmed/35855914
http://dx.doi.org/10.1186/s40537-022-00643-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281265/
https://www.ncbi.nlm.nih.gov/pubmed/35855914
http://dx.doi.org/10.1186/s40537-022-00643-x

Ejemplares similares